Journal of Biological Chemistry · 2003 · 62 citations · 36 references
Life SciencesImmunologyPhysiologyCellular MetabolismInflammationInnate ImmunityImmune Cell PhysiologyInflammatory Cell ResponsesInflammatory Response RegulationInflammatory SignalingMitochondrial PhysiologyOxidative Stress In InflammationAnti-inflammatory ResponseInflammatory CascadeMetabolic Regulation Of InflammationOxidative Stress InjuryRedox Metabolism In Inflammatory DiseaseUncoupling Proteins
The mitochondrial uncoupling protein 2 (UCP2) is expressed in spleen, lung, intestine, white adipose tissue, and immune cells. Bone marrow transplantation in mice was used to assess the contribution of immune cells to the expression of UCP2 in basal condition and during inflammation. Immune cells accounted for the total amount of UCP2 expression in the spleen, one-third of its expression in the lung, and did not participate in its expression in the intestine. LPS injection stimulated UCP2 expression in lung, spleen, and intestine in both immune and non-immune cells. Successive injections of LPS and dexamethasone or N-acetyl-cysteine prevented the induction of UCP2 in all three tissues, suggesting that oxygen free radical generation plays a role in UCP2 regulation. Finally, both previous studies and our data show that there is down-regulation of UCP2 in immune cells during their activation in the early stages of the LPS response followed by an up-regulation in UCP2 during the later stages to protect all cells against oxidative stress. The mitochondrial uncoupling protein 2 (UCP2) is expressed in spleen, lung, intestine, white adipose tissue, and immune cells. Bone marrow transplantation in mice was used to assess the contribution of immune cells to the expression of UCP2 in basal condition and during inflammation. Immune cells accounted for the total amount of UCP2 expression in the spleen, one-third of its expression in the lung, and did not participate in its expression in the intestine. LPS injection stimulated UCP2 expression in lung, spleen, and intestine in both immune and non-immune cells. Successive injections of LPS and dexamethasone or N-acetyl-cysteine prevented the induction of UCP2 in all three tissues, suggesting that oxygen free radical generation plays a role in UCP2 regulation. Finally, both previous studies and our data show that there is down-regulation of UCP2 in immune cells during their activation in the early stages of the LPS response followed by an up-regulation in UCP2 during the later stages to protect all cells against oxidative stress. UCP2 1The abbreviations used are: UCP2, mitochondrial uncoupling protein 2; ROS, reactive oxygen species; COX I, cytochrome c oxydase subunit I; LPS, lipopolysaccharide; LDL R -/-, low density lipoprotein receptor-deficient mice; MOMA-2, anti-mouse macrophage/monocyte; TNFα, tumor necrosis factor α; NAC, N-acetyl-cysteine. belongs to a newly discovered subgroup of mitochondrial carrier proteins related to the well known UCP1 from brown adipose tissue (for review, see Ref. 1Ricquier D. Bouillaud F. Biochem. J. 2000; 345: 161-179Crossref PubMed Scopus (754) Google Scholar). Unlike UCP1, UPC2 and its related family member UCP3 do not seem to be involved in cold-adapted thermogenesis. Studies on Ucp2 -/- mice revealed two intriguing phenotypes (for review, see Ref. 2Alves-Guerra M.C. Pecqueur C. Shaw A. Couplan E. Gonzalez-Barroso M.M. Ricquier D. Bouillaud F. Miroux B. Storey K.B. Storey J.M. Cell and Molecular Responses to Stress: Sensing, Signaling and Cell Adaptation. 3. Elsevier Press, Amsterdam, The Netherlands2002: 257-268Google Scholar). Zhang et al. (3Zhang C.Y. Baffy G. Perret P. Krauss S. Peroni O. Grujic D. Hagen T. Vidal-Puig A.J. Boss O. Kim Y.B. Zheng X.X. Wheeler M.B. Shulman G.I. Chan C.B. Lowell B.B. Cell. 2001; 105: 745-755Abstract Full Text Full Text PDF PubMed Scopus (825) Google Scholar) found that Ucp2 -/- mice exhibit higher serum insulin and lower blood glucose levels compared with wild-type mice. In vitro, pancreatic islets from Ucp2 -/- mice had increased insulin secretion in response to glucose, which was correlated to a higher ATP level (3Zhang C.Y. Baffy G. Perret P. Krauss S. Peroni O. Grujic D. Hagen T. Vidal-Puig A.J. Boss O. Kim Y.B. Zheng X.X. Wheeler M.B. Shulman G.I. Chan C.B. Lowell B.B. Cell. 2001; 105: 745-755Abstract Full Text Full Text PDF PubMed Scopus (825) Google Scholar). Arsenijevic et al. (4Arsenijevic D. Onuma H. Pecqueur C. Raimbault S. Manning B.S. Miroux B. Couplan E. Alves-Guerra M.C. Goubern M. Surwit R. Bouillaud F. Richard D. Collins S. Ricquier D. Nat. Genet. 2000; 26: 435-439Crossref PubMed Scopus (942) Google Scholar) found an improvement of the macrophage oxidative burst activity in Ucp2 -/- mice. Macrophages isolated from Ucp2 -/- mice infected with Toxoplasma gondii produced more reactive oxygen species (ROS) and had a higher toxoplasmacidal activity compared with wild-type mice (4Arsenijevic D. Onuma H. Pecqueur C. Raimbault S. Manning B.S. Miroux B. Couplan E. Alves-Guerra M.C. Goubern M. Surwit R. Bouillaud F. Richard D. Collins S. Ricquier D. Nat. Genet. 2000; 26: 435-439Crossref PubMed Scopus (942) Google Scholar). This enhanced macrophage oxidative activity was also confirmed in another mouse model. LDL R -/- mice, which are susceptible to atherosclerosis when fed an atherogenic diet, were transplanted with bone marrow cells from either Ucp2 -/- or Ucp2 +/+ littermate mice. In this mouse model of atherosclerosis, the lack of UCP2 accelerated the development of unstable atherosclerotic plaques, showing a protective role for UCP2 in atherosclerosis (5Blanc J. Alves-Guerra M.C. Esposito B. Rousset S. Gourdy P. Ricquier D. Tedgui A. Miroux B. Mallat Z. Circulation. 2003; 107: 388-390Crossref PubMed Scopus (212) Google Scholar). Altogether, these results suggest that UCP2 acts as a mild uncoupler, controlling both ATP synthesis as well as the production of ROS (4Arsenijevic D. Onuma H. Pecqueur C. Raimbault S. Manning B.S. Miroux B. Couplan E. Alves-Guerra M.C. Goubern M. Surwit R. Bouillaud F. Richard D. Collins S. Ricquier D. Nat. Genet. 2000; 26: 435-439Crossref PubMed Scopus (942) Google Scholar, 6Skulachev V.P. Q. Rev. Biophys. 1996; 29: 169-202Crossref PubMed Google Scholar, 7Negre-Salvayre A. Hirtz C. Carrera G. Cazenave R. Troly M. Salvayre R. Penicaud L. Casteilla L. FASEB J. 1997; 11: 809-815Crossref PubMed Scopus (685) Google Scholar). However, conflicting data have been obtained regarding the respiratory coupling state of Ucp2 -/- and Ucp3 -/- mice mitochondria (8Cline G.W. Vidal-Puig A.J. Dufour S. Cadman K.S. Lowell B.B. Shulman G.I. J. Biol. Chem. 2001; 276: 20240-20244Abstract Full Text Full Text PDF PubMed Scopus (122) Google Scholar, 9Couplan E. del Mar Gonzalez-Barroso M. Alves-Guerra M.-C. Ricquier D. Goubern M. Bouillaud F. J. Biol. Chem. 2002; 277: 26268-26275Abstract Full Text Full Text PDF PubMed Scopus (140) Google Scholar, 10Echtay K.S. Roussel D. St-Pierre J. Jekabsons M.B. Cadenas S. Stuart J.A. Harper J.A. Roebuck S.J. Morrison A. Pickering S. Clapham J.C. Brand M.D. Nature. 2002; 415: 96-99Crossref PubMed Scopus (1150) Google Scholar, 11Krauss S. Zhang C.Y. Lowell B.B. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 118-122Crossref PubMed Scopus (154) Google Scholar, 12Vidal-Puig A.J. Grujic D. Zhang C.Y. Hagen T. Boss O. Ido Y. Szczepanik A. Wade J. Mootha V. Cortright R. Muoio D.M. Lowell B.B. J. Biol. Chem. 2000; 275: 16258-16266Abstract Full Text Full Text PDF PubMed Scopus (591) Google Scholar). Although the uncoupling activity of all UCPs has been established in vitro in proteoliposomes (13Jaburek M. Garlid K.D. J. Biol. Chem. 2003; 278: 25825-25831Abstract Full Text Full Text PDF PubMed Scopus (100) Google Scholar, 14Echtay K.S. Winkler E. Frischmuth K. Klingenberg M. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 1416-1421Crossref PubMed Scopus (310) Google Scholar, 15Jaburek M. Varecha M. Gimeno R.E. Dembski M. Jezek P. Zhang M. Burn P. Tartaglia L.A. Garlid K.D. J. Biol. Chem. 1999; 274: 26003-26007Abstract Full Text Full Text PDF PubMed Scopus (285) Google Scholar) and yeast or mammalian mitochondria (16Fink B.D. Hong Y.S. Mathahs M.M. Scholz T.D. Dillon J.S. Sivitz W.I. J. Biol. Chem. 2002; 277: 3918-3925Abstract Full Text Full Text PDF PubMed Scopus (64) Google Scholar, 17Rial E. Gonzalez-Barroso M. Fleury C. Iturrizaga S. Sanchis D. Jimenez-Jimenez J. Ricquier D. Goubern M. Bouillaud F. EMBO J. 1999; 18: 5827-5833Crossref PubMed Scopus (179) Google Scholar), the in vivo activity of UCP2 and UCP3 is still a matter of debate. Another approach to understanding the physiological roles of UCP2 has been to study the expression of the protein in wild-type mice. The detection of UCP2 protein is difficult for two main reasons. First, UCP2 is at least 160-fold less abundant in spleen mitochondria than UCP1 is in brown adipose tissue. Second, most of the anti-peptide antibodies cross-react with other mitochondrial carriers and, therefore, are misleading. Nevertheless, with the help of the Ucp2 -/- mice as negative controls, a highly sensitive anti-UCP2 polyclonal antibody suitable for in vivo detection of UCP2 has been characterized. UCP2 was found to be expressed in spleen, lung, intestine, and, at lower levels, in white adipose tissue (18Pecqueur C. Alves-Guerra M.C. Gelly C. Levi-Meyrueis C. Couplan E. Collins S. Ricquier D. Bouillaud F. Miroux B. J. Biol. Chem. 2001; 276: 8705-8712Abstract Full Text Full Text PDF PubMed Scopus (412) Google Scholar). Taking as given the immunologic phenotype of Ucp2 -/- mice (4Arsenijevic D. Onuma H. Pecqueur C. Raimbault S. Manning B.S. Miroux B. Couplan E. Alves-Guerra M.C. Goubern M. Surwit R. Bouillaud F. Richard D. Collins S. Ricquier D. Nat. Genet. 2000; 26: 435-439Crossref PubMed Scopus (942) Google Scholar), the induction of the protein after LPS treatment (18Pecqueur C. Alves-Guerra M.C. Gelly C. Levi-Meyrueis C. Couplan E. Collins S. Ricquier D. Bouillaud F. Miroux B. J. Biol. Chem. 2001; 276: 8705-8712Abstract Full Text Full Text PDF PubMed Scopus (412) Google Scholar), and the presence of immune cells in almost all organs where UCP2 protein was found (18Pecqueur C. Alves-Guerra M.C. Gelly C. Levi-Meyrueis C. Couplan E. Collins S. Ricquier D. Bouillaud F. Miroux B. J. Biol. Chem. 2001; 276: 8705-8712Abstract Full Text Full Text PDF PubMed Scopus (412) Google Scholar), we set out to determine the precise contribution of immune cells in the expression of UCP2. In the absence of antibodies suitable for in situ detection of UCP2, bone marrow transplantation between Ucp2 -/- and Ucp2 +/+ mice was performed. Levels of UCP2 in all groups of mice were assessed at basal conditions after LPS treatment. To provoke liver injury, mice were also fed an atherogenic diet. Finally, we investigated the effects of N-acetyl-cysteine and dexamethasone on the expression of UCP2 in the LPS model. Animals and Treatments—Studies on mice were performed in agreement with the institutional CNRS guidelines defined by the European Community guiding principles and by the French decree No. 87/848 of October 19, 1987. Authorization to perform animal experiments was given by the French Ministry of Agriculture, Fisheries and Food (permit A92580 was issued February 2, 1994 and 92-148 was issued May 14, 2002). All mice were 7-10 weeks old. Ucp2 -/- mice have been described previously. The mice were transferred onto a C57BL/6J genetic background (99.2%). C57BL/6J mice were purchased from Elevage Janvier (Orleans, France). Mice were injected intraperitoneally with various concentrations of LPS from Escherichia coli serotype 055:B5 (Sigma) and left with free access to food and water. Rectal temperature was measured with a thermocouple probe thermometer (CHY 508BR, Bioseb, Chaville, France). Mice were killed 14 h after injection. Atherogenic diet was purchased from UAR (Epinay sur Orge, France) and consisted of an A03 diet complete with 15% cocoa butter, 1.25% cholesterol, and 0.5% sodium cholate. Medullar aplasia was induced by 9.5 Gy total body irradiation. Mice were injected intravenously under anesthesia with bone marrow cells (1.2 × 106) extracted from the femur and tibia of either Ucp2 +/+ or Ucp2 -/- mice. The Ucp2 +/+ mice that received bone marrow from Ucp2 -/- mice were named Ucp2 +/+tKO, and the Ucp2 -/- mice that received bone marrow from Ucp2 +/+ were named Ucp2 -/-tWT. Macrophage engraftment of hemapoietic tissues after bone marrow transplantation requires one month, whereas the engraftment of Kuppfer cells in liver or of resident lung macrophages requires 3-6 months (19Kennedy D.W. Abkowitz J.L. Blood. 1997; 90: 986-993Crossref PubMed Google Scholar, 20Nakata K. Gotoh H. Watanabe J. Uetake T. Komuro I. Yuasa K. Watanabe S. Ieki R. Sakamaki H. Akiyama H. Kudoh S. Naitoh M. Satoh H. Shimada K. Blood. 1999; 93: 667-673Crossref PubMed Google Scholar). Therefore, transplanted mice were allowed to recover for 4 months to ensure that the engraftment of resident macrophages was close to completion. Transplanted mice were either fed an atherogenic diet for 12 additional weeks or treated with LPS. Morphometric Analyses—The aortic sinus and aorta of the mice were frozen. Serial sections of the aortic sinus were assayed for lipid deposition with oil red O. Immunohistochemistry was performed as described previously (21Mallat Z. Silvestre J.S. Le Ricousse-Roussanne S. Lecomte-Raclet L. Corbaz A. Clergue M. Duriez M. Barateau V. Akira S. Tedgui A. Tobelem G. Chvatchko Y. Levy B.I. Circ. Res. 2002; 91: 441-448Crossref PubMed Scopus (58) Google Scholar) using a monoclonal rat anti-mouse macrophage antibody, clone MOMA-2 (BIOSOURCE International). Biochemical Methods: Isolation of Mitochondria and Western were out at 4 tissues were in with the 4 2 and tissue was in a at low cells and were by two of the at × for Mitochondria were after of the at × for and protein was assayed using a The anti-UCP2 antibody and the Western conditions have been described previously (18Pecqueur C. Alves-Guerra M.C. Gelly C. Levi-Meyrueis C. Couplan E. Collins S. Ricquier D. Bouillaud F. Miroux B. J. Biol. Chem. 2001; 276: 8705-8712Abstract Full Text Full Text PDF PubMed Scopus (412) Google Scholar). c oxydase subunit monoclonal antibody and monoclonal antibody were purchased from Molecular The and used at of the was performed with the of the and was using France). are expressed as between groups were by using a of In the the be and was as LPS 055:B5 UCP2 in the induction of UCP2 protein 14 h after LPS injection. In to the LPS serotype used in our previous study (18Pecqueur C. Alves-Guerra M.C. Gelly C. Levi-Meyrueis C. Couplan E. Collins S. Ricquier D. Bouillaud F. Miroux B. J. Biol. Chem. 2001; 276: 8705-8712Abstract Full Text Full Text PDF PubMed Scopus (412) Google Scholar), the LPS serotype 055:B5 increased UCP2 not in lung also in spleen and an LPS of UCP2 levels increased in spleen UCP2 levels in the lung and were increased and at an LPS of these levels of expression were less than in the spleen which is the of UCP2 expression in the conditions the of the liver in the response to and previous results obtained by et al. R. J. A. C. Biochem. Biophys. Res. PubMed Scopus Google Scholar) and et al. H. S. M.D. G. Biochem. Biophys. Res. PubMed Scopus Google Scholar), we the induction of UCP2 in liver by LPS treatment. a of this LPS serotype UCP2 increased to a level by our antibody and of the basal level of UCP2 in lung The protein UCP2 is still in liver mitochondria from Ucp2 -/- and therefore, not of UCP2 in liver mitochondria LPS treatment or atherogenic diet. Ucp2 +/+ mice were and transplanted with bone marrow from Ucp2 -/- littermate mice, whereas Ucp2 -/- mice were transplanted with bone marrow from Ucp2 +/+ littermate mice. months after Ucp2 +/+ mice, Ucp2 -/- mice, Ucp2 mice, and Ucp2 mice were to LPS injection or to an atherogenic diet. Western of UCP2 induction in liver mitochondria after LPS or injection. of the atherogenic diet on Ucp2 -/- and Ucp2 +/+ mice. Serial sections of the aortic sinus were assayed for lipid deposition with The the atherosclerotic were also measured on both groups of mice. Western of the expression of UCP2 in liver after the atherogenic diet. COX antibody was used to the amount of mitochondrial protein of MOMA-2 in red of liver sections from Ucp2 +/+ mice and Ucp2 mice on diet and from Ucp2 after the atherogenic Bone the of Immune to UCP2 of UCP2 in liver has been described in mice fed a oil diet M. Kim H. O. Biochem. Biophys. Res. 1999; PubMed Scopus Google Scholar), mice R. J. A. C. Biochem. Biophys. Res. PubMed Scopus Google Scholar), and mice K.D. S. J. V.P. E. A. M.D. J. Biol. Chem. 1999; 274: Full Text Full Text PDF PubMed Scopus Google Scholar, A. 1999; 29: PubMed Scopus Google Scholar, S. H. Y. H. K. Biochem. Biophys. 2000; PubMed Scopus Google Scholar). In these animal liver and is therefore, that the expression of UCP2 is to resident or To this bone marrow transplantation was performed. Ucp2 +/+ mice, Ucp2 -/- mice, Ucp2 mice, and Ucp2 mice were fed an atherogenic diet or were treated with LPS. LPS treatment UCP2 protein was induced in liver from Ucp2 +/+ and Ucp2 mice that LPS induced UCP2 in weeks of an atherogenic diet the of atherosclerotic in both the Ucp2 -/- and Ucp2 +/+ groups of mice was with our previous study on transplanted LDL R -/- mice fed a atherogenic diet (5Blanc J. Alves-Guerra M.C. Esposito B. Rousset S. Gourdy P. Ricquier D. Tedgui A. Miroux B. Mallat Z. Circulation. 2003; 107: 388-390Crossref PubMed Scopus (212) Google Scholar), the of the atherosclerotic was increased in Ucp2 -/- mice compared with Ucp2 +/+ In to the LPS model of the atherogenic diet induced UCP2 protein in liver mitochondria from Ucp2 +/+ and Ucp2 mice not in liver mitochondria from Ucp2 mice This that the level of UCP2 protein of the level of UCP2 in in response to an atherogenic diet is with immune cells and not with To this sections of liver were with the MOMA-2 antibody macrophages were in both Ucp2 +/+ mice and in Ucp2 mice, showing that 4 months after bone marrow of the liver by immune cells has revealed by the MOMA-2 the atherogenic diet in the presence of a of macrophages in the liver of Ucp2 mice In spleen, expression of UCP2 almost in the Ucp2 mice showing that UCP2 protein is more than with immune cells in this In expression of UCP2 in in Ucp2 mice, the expression of UCP2 intestine cells an amount of UCP2 protein is in the lung of Ucp2 to of the found in mice. To that the transplantation was wild-type mice were also transplanted with wild-type bone marrow and the level of UCP2 in spleen was measured in all groups of mice. in the levels of UCP2 protein in the spleen of Ucp2 and Ucp2 mice were to the level of UCP2 in the spleen of wild-type mice. LPS injection stimulated UCP2 protein in spleen of Ucp2 mice not However, in the lung, of UCP2 expression in both groups of mice showing that 14 h after both immune and non-immune cells UCP2. In intestine, a UCP2 protein in the Ucp2 mice treated with LPS not in to the induction of UCP2 by intestine a of immune cells to UCP2 induction by LPS. of and after LPS that UPC2 to the induced by LPS, mice were injected intraperitoneally with LPS and h with either N-acetyl-cysteine or dexamethasone the of LPS induced a with body temperature to N-acetyl-cysteine and dexamethasone the body temperature or and prevented UCP2 induction in spleen, lung, and and Bone of spleen, UCP2 expression is to immune which that UCP2 is expressed in macrophages and as previously (4Arsenijevic D. Onuma H. Pecqueur C. Raimbault S. Manning B.S. Miroux B. Couplan E. Alves-Guerra M.C. Goubern M. Surwit R. Bouillaud F. Richard D. Collins S. Ricquier D. Nat. Genet. 2000; 26: 435-439Crossref PubMed Scopus (942) Google Scholar, 11Krauss S. Zhang C.Y. Lowell B.B. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 118-122Crossref PubMed Scopus (154) Google Scholar). However, immune cells do not to the UCP2 protein in intestine. The lung an In expression of UCP2 be to either or to resident and immune on the model. The presence of in the atherogenic diet, which a of the macrophage whereas LPS which a for a of is not to a of immune cells. All these data that immune cells are a for UCP2 which be when UCP2 expression in the of UCP2 during has been to in and, the oxidative burst activity in the lung of mice D. B. R. T. A. 2000; PubMed Scopus Google Scholar). also the the production of and as TNFα, and and macrophage D. B. R. T. A. 2000; PubMed Scopus Google Scholar, J. M. D. P. M. C. M. B.B. J. Google Scholar). In a on D. B. R. T. A. 2000; PubMed Scopus Google Scholar, S. R. B. P. 91: PubMed Scopus Google Scholar), in lung tissue, as by et al. J. PubMed Scopus Google Scholar) in a model of respiratory The effects of dexamethasone and on UCP2 induction by LPS suggest that free the expression of UCP2 either at the level as described by Pecqueur et al. (18Pecqueur C. Alves-Guerra M.C. Gelly C. Levi-Meyrueis C. Couplan E. Collins S. Ricquier D. Bouillaud F. Miroux B. J. Biol. Chem. 2001; 276: 8705-8712Abstract Full Text Full Text PDF PubMed Scopus (412) Google Scholar) or at the In the that UCP2 is by levels be LPS injection in mice an in blood level in less than 2 which is followed by and an of in the of the lung J. M. D. P. M. C. M. B.B. J. Google Scholar). UCP2 induction after the of blood However, et al. R. C. Biophys. 2000; PubMed Scopus Google Scholar) that is not for the up-regulation of UCP2 levels in the mice, and et al. T. M. S. O. J. Biol. Chem. 2002; 277: Full Text Full Text PDF PubMed Scopus Google Scholar) that liver Ucp2 by of a a of in of UCP2 in Immune expression in immune cells LPS treatment has been in vitro by described a down-regulation of UCP2 in macrophages 4 h after LPS treatment (4Arsenijevic D. Onuma H. Pecqueur C. Raimbault S. Manning B.S. Miroux B. Couplan E. Alves-Guerra M.C. Goubern M. Surwit R. Bouillaud F. Richard D. Collins S. Ricquier D. Nat. Genet. 2000; 26: 435-439Crossref PubMed Scopus (942) Google Scholar). and et al. Y. A.J. J. 1999; 276: PubMed Google Scholar) the with LPS treatment and that mice a down-regulation of UCP2 in et al. T. K. Y. D. Watanabe K. K. H. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: PubMed Scopus Google Scholar) also described a down-regulation of UCP2 and protein in macrophages h after LPS treatment. groups that this in an in reactive oxygen the of expression and the production of and with this et al. Z. Zhang J. Biochem. Biophys. Res. 2002; PubMed Scopus Google Scholar) described a of UCP2 in bone cells after LPS treatment and a in the expression of In to these in vitro bone marrow transplantation revealed an of UCP2 protein in immune cells h after LPS treatment. are either UCP2 is immune or immune cells are the In the spleen, the more whereas in the lung and a of immune cells be previous studies and our data a model of UCP2 of an early and a response to LPS In the early of the LPS UCP2 down-regulation macrophages an increased production of ROS, which to the activation of macrophages and to the secretion of as and This is with the that Ucp2 -/- macrophages are after with T. gondii (4Arsenijevic D. Onuma H. Pecqueur C. Raimbault S. Manning B.S. Miroux B. Couplan E. Alves-Guerra M.C. Goubern M. Surwit R. Bouillaud F. Richard D. Collins S. Ricquier D. Nat. Genet. 2000; 26: 435-439Crossref PubMed Scopus (942) Google Scholar). a later h after LPS have induced a oxidative and there is a to the effects of and of immune cells. of UCP2 expression be as an response to the production of ROS in immune cells in a negative and also in non-immune tissues as the lung and Finally, these data suggest the that UCP2 as either a or an on its mitochondrial low levels, UCP2 in the activation of immune their oxidative burst higher levels, UCP2 to a against an of oxygen free for of the and for animal
36
Superoxide activates mitochondrial uncoupling proteins
Karim S. Echtay, Damien Roussel, Julie St‐Pierre et al. · Nature · 2002 · 1.4K citations